12 (S)-hydroxyeicosatetraenoic acid levels link to coronary artery disease in type 2 diabetic patients

HJ Zhang, CH Sun, HY Kuang, XY Jiang, HL Liu… - Journal of …, 2013 - Springer
HJ Zhang, CH Sun, HY Kuang, XY Jiang, HL Liu, WF Hua, ZJ Liu, H Zhou, H Sui, R Qi
Journal of Endocrinological Investigation, 2013Springer
Abstract Background: 12 (S)-Hydroxyeicosatetraenoic acid (12 (S)-HETE) is a metabolite of
arachidonic acid. 12 (S)-HETE is involved in the pathogenesis of atherosclerosis and
diabetes. However, the correlation between 12 (S)-HETE and coronary artery disease (CAD)
in the diabetic patient is unclear. Aims: The study investigated the relationship between 12
(S)-HETE and CAD in Type 2 diabetes (T2D). Methods: Plasma 12 (S)-HETE levels were
detected by enzyme-linked immunosorbent assay in 103 healthy controls (control), 109 …
Abstract
Background: 12(S)-Hydroxyeicosatetraenoic acid (12(S)-HETE) is a metabolite of arachidonic acid. 12(S)-HETE is involved in the pathogenesis of atherosclerosis and diabetes. However, the correlation between 12(S)-HETE and coronary artery disease (CAD) in the diabetic patient is unclear. Aims: The study investigated the relationship between 12(S)-HETE and CAD in Type 2 diabetes (T2D). Methods: Plasma 12(S)-HETE levels were detected by enzyme-linked immunosorbent assay in 103 healthy controls (control), 109 diabetic patients without CAD (diabetic), and 152 diabetic patients with CAD (diabetic-CAD). Results: 12(S)-HETE levels were higher in both diabetic and diabetic-CAD groups compared to control and in the diabetic-CAD group compared to the diabetic group. In the multiple linear stepwise regression analysis, 12(S)-HETE levels correlated independently with CAD, systolic blood pressure, and glycated hemoglobin. Conclusions: These results indicate that 12(S)-HETE levels are increased in diabetic patients with CAD, suggesting a role for atherosclerosis in T2D.
Springer